SARS-CoV-2 spike–reactive B cells, CD4+ T cells and, to a lesser extent, CD8+ T cells have been described in the majority of convalescent COVID-19 patients (4), including those with mild or asymptomatic infection (5), with formation of substantial immune memory across convalescent individuals (6). This evidence concerns the gene CD4 and COVID-19.